MedTrace Logo

Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV

NCT01040039 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2013-05-17

No results posted yet for this study

Summary

This pilot study aims to study gut B cells in HCV+HIV+, HCV+HIV-, HCV-HIV+, and HCV-HIV- volunteers. Volunteers will undergo a screening blood draw and flexible sigmoidoscopy with biopsy.

Conditions

  • HIV Infections
  • Hepatitis C Virus

Sponsors & Collaborators

  • Rockefeller University

    lead OTHER

Principal Investigators

  • Edgar Charles, MD · Rockefeller University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01040039 on ClinicalTrials.gov